Journal of Psychopharmacology Issues Research Articles in May 2022 Edition
May 18, 2022
May 18, 2022
LONDON, England, May 18 -- The Journal of Psychopharmacology, a peer-reviewed journal that says it features preclinical and clinical aspects of psychopharmacology, published research articles, including the following topics, in its May 2022 edition:
Reviews:
* Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review
* The antidepressant effect and safety of non-intranasal esketamine: . . .
Reviews:
* Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review
* The antidepressant effect and safety of non-intranasal esketamine: . . .